Who is sponsoring NCT05322265?

NCT05322265 is sponsored by University of Palermo.

What drugs are being tested in NCT05322265?

Interventions in NCT05322265: laparoscopic surgery for renal and adrenal diseases.

What condition does NCT05322265 study?

NCT05322265 studies Adrenal Disease, Renal Cancer, Surgery--Complications.

Is NCT05322265 still recruiting?

NCT05322265 is currently status unknown. Last updated 11 April 2022.

Last reviewed 2022-04-11 · How we verify

NCT05322265: CLARAS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Complication in Laparoscopic Renal and Adrenal Surgery (CLARAS)

Status unknown Last updated 11 April 2022

What this trial tests

trial testing laparoscopic surgery for renal and adrenal diseases in Adrenal Disease in 350 participants. Status unknown.

Timeline

1 April 2017

Primary endpoint
31 March 2022

30 May 2022

Quick facts

Lead sponsor	University of Palermo
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	350
Start date	1 April 2017
Primary completion	31 March 2022
Estimated completion	30 May 2022
Sites	1 location across Italy

Drugs / interventions tested

laparoscopic surgery for renal and adrenal diseases

Conditions studied

Adrenal Disease — all drugs for Adrenal Disease →
Renal Cancer — all drugs for Renal Cancer →
Surgery--Complications — all drugs for Surgery--Complications →

Sponsor

University of Palermo

Who can join

Adults 18 to 89, any sex, with Adrenal Disease or Renal Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

the aim of this study is clarify complication and their resolution in laparoscopic renal and adrenal surgery.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Evaluation of predictive factors for i-CLARAS (intraoperative complications in laparoscopic renal and adrenal surgery): a multicentre international retrospective cohort study.
Territo A, Di Buono G, Buscemi S, Mantica G, et al · · 2024 · cited 2× · PMID 38228705 · DOI 10.1038/s41598-024-51696-2

Verify or expand the search:

Other recruiting trials for Adrenal Disease

Currently open trials in the same condition.

NCT07191951 — Shanghai Clinical Cohort - Adrenal Disease · recruiting
NCT06050057 — Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy · recruiting

Other University of Palermo trials

Trials by the same sponsor.

NCT03017716 — Inflammatory Back Pain and Gluten Free Diet · NA · not yet recruiting
NCT07364149 — Acute Effects of Structured Exercise and Static Stretching on Vascular Function, Neuromuscular Performance, and Metaboli · NA · recruiting
NCT06206616 — Liver Steatosis in Pediatric CD Patients · not yet recruiting
NCT07433543 — Foam Rolling, Blood Pressure and Range of Motion · NA · completed
NCT07213011 — Effects of Static Stretching and Self-myofascial Release on Local and Remote Range of Motion · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05322265 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Palermo
Last refreshed: 11 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05322265.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing